Journal & Society News

• 2010 Relaunch of BJP
• Published on Jan 26, 2010

BJP's new, fresh, blue cover design harmonises the journal with the similar green cover of its sister journal, BJCP, symbolically indicating that the two BPS journals are now working together under one publisher to cover all of pharmacology. The new design reflects the British Pharmacological Society logo.

• New GRAC published - FREE access online
• Published on Nov 17, 2009

The 2009 Guide to Receptors and Channels is now available, providing user-friendly overviews of key pharmacological targets: 7TM receptors, ligand-gated ion channels, ion channels, catalytic receptors, nuclear receptors, transporters, and enzymes. Prepared in association with NC-IUPHAR, this updated and expanded 4th Edition is an essential reference work (and nomenclature guide) that allows a newcomer to a particular target group to identify the main elements "at a glance".

• New hope for sufferers of overactive bladder
• Published on Oct 29, 2009

It’s an embarrassing condition affecting hundreds of thousands of Australians, yet it’s something no-one likes to talk about. Now sufferers of overactive bladder have been given hope of a more effective treatment following a breakthrough by UNSW medical researchers.

• Neuropathic Pain: The Sea Provides A New Hope Of Relief
• Published on Aug 05, 2009

A compound initially isolated from a soft coral (Capnella imbricata) collected at Green Island off Taiwan, could lead scientists to develop a new set of treatments for neuropathic pain.

• Increased Impact Factors for both BPS Journals
• Published on Jun 25, 2009

We are delighted to announce that the 2008 Impact Factor for BJP (British Journal of Pharmacology) is 4.902*. This places BJP as the highest ranked general pharmacology research journal, now ranked 18th in the ISI Pharmacology & Pharmacy category*.

• Upcoming BPS Meetings
• Published on Jun 01, 2009

8-10 July, 2009 BPS Summer Meeting University of Edinburgh, UK...  

• Angina: New Drug Gets Right to the Heart of the Problem
• Published on Jan 07, 2009

A compound designed to prevent chest pains in heart patients has shown promising results in animal studies, say scientists. In the second issue of the British Journal of Pharmacology to be published by Wiley-Blackwell, researchers from the Centre de Recherche Pierre Fabre in France, show that the novel compound F15845 has anti-angina activity and can protect heart cells from damage without the unwanted side effects often experienced with other drugs.

• The Promega UK Young Life Scientist Awards
• Published on Jan 06, 2009